HighTower Advisors’s Cantel Medical Corporation CMD Stock Holding History

HighTower Advisors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,056	Closed	-$287K	–	2423
2017 Q3	$287K	Buy	+3,056	New	+$241K	﹤0.01%	1709
2017 Q2	–	Sell	-2,519	Closed	-$202K	–	2362
2017 Q1	$202K	Buy	+2,519	New	+$200K	﹤0.01%	1768
2016 Q4	–	Sell	-4,976	Closed	-$386K	–	2077
2016 Q3	$386K	Buy	+4,976	New	+$361K	﹤0.01%	1352
2016 Q2	–	Sell	-1,871	Closed	-$134K	–	2082
2016 Q1	$134K	Buy	+1,871	New	+$117K	﹤0.01%	1874

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

HighTower Advisors's CMD Position: Q4 2017 in Review

HighTower Advisors sold out of Cantel Medical Corporation (CMD) in Q4 2017, closing a stake of 3,056 shares — an estimated $287K sold.

HighTower Advisors first reported a position in CMD in Q1 2016 and held it in 4 quarters. The position peaked at $386K in Q3 2016. 245 funds tracked by Wall St. Rank hold CMD as of Q4 2017.

HighTower Advisors reported no remaining Cantel Medical Corporation position as of Q4 2017 after selling out during the quarter.
HighTower Advisors sold 3,056 Cantel Medical Corporation shares in Q4 2017, an estimated $287K.
HighTower Advisors first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 4 quarters.
HighTower Advisors's Cantel Medical Corporation position peaked at $386K in Q3 2016.
245 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2017.

Based on HighTower Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.